Sino-Argi Leading Biosciences (603970) — Free Cash Flow Generation Index
Sino-Argi Leading Biosciences (603970) has a Free Cash Flow Generation Index of 1.00x as of December 2024. Free cash flow of CN¥700.89 Million represents 1% of operating cash flow (CN¥702.54 Million). Explore Sino-Argi Leading Biosciences (603970) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sino-Argi Leading Biosciences Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for Sino-Argi Leading Biosciences across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Sino-Argi Leading Biosciences.
Annual Free Cash Flow Generation for Sino-Argi Leading Biosciences (2012–2024)
Year-by-year Free Cash Flow Generation Index for Sino-Argi Leading Biosciences. Check Sino-Argi Leading Biosciences investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.99x | CN¥305.21 Million | CN¥307.40 Million | CN¥2.18 Million | ▼ -0.5% |
| 2022 | 1.00x | CN¥1.53 Billion | CN¥1.54 Billion | CN¥3.44 Million | ▲ +1.0% |
| 2021 | 0.99x | CN¥321.43 Million | CN¥325.42 Million | CN¥3.99 Million | ▲ +3.2% |
| 2020 | 0.96x | CN¥337.13 Million | CN¥352.12 Million | CN¥14.99 Million | ▼ -3.1% |
| 2019 | 0.99x | CN¥216.23 Million | CN¥218.90 Million | CN¥2.67 Million | ▲ +14.4% |
| 2018 | 0.86x | CN¥56.70 Million | CN¥65.69 Million | CN¥8.99 Million | ▼ -3.4% |
| 2017 | 0.89x | CN¥463.44 Million | CN¥518.83 Million | CN¥55.39 Million | ▲ +17.9% |
| 2016 | 0.76x | CN¥115.37 Million | CN¥152.22 Million | CN¥36.85 Million | ▼ -10.5% |
| 2014 | 0.85x | CN¥34.24 Million | CN¥40.41 Million | CN¥6.17 Million | ▼ -13.9% |
| 2012 | 0.98x | CN¥107.70 Million | CN¥109.43 Million | CN¥1.74 Million | — |